Critical review of complementary therapies for prostate cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Simon Wilkinson, Gerald W Chodak

Abstract

Despite its prominence as the most frequently diagnosed solid tumor among men in the United States, relatively little is known about the etiology of prostate cancer. Furthermore, research into treatment strategies for prostate cancer continues to lag behind research for the other most common cancers. At the same time, however, the popularity of complementary therapies among prostate cancer patients continues to grow. In this article, we provide a critical review of the most recent evidence for dietary modifications, food supplements, and herbs in prostate cancer prevention and treatment. Despite encouraging data for some of these interventions, even the strongest proponents of complementary therapy agree that only randomized controlled trials can provide sufficient evidence on which to create universal guidelines. However, such trials are highly complex and expensive, and they require lengthy follow-up. Until such trials are completed, an opportunity exists for health care professionals to improve their knowledge and understanding of the current evidence for or against complementary therapy in prostate cancer.

References

Mar 1, 1992·British Journal of Cancer·A R WalkerA J Walker
Jan 1, 1991·Urologia Internationalis·M P BravoJ del Rey Calero
Jun 6, 1990·Journal of the National Cancer Institute·A W HsingB F Polk
Apr 1, 1989·The Journal of Nutrition·J D Ribaya-MercadoR M Russell
Nov 1, 1988·Cancer·R B HayesO Yoshida
May 1, 1988·American Journal of Epidemiology·L N KolonelJ H Hankin
Jul 31, 1985·Biochemical and Biophysical Research Communications·M M WebberG T James
Jan 1, 1985·The Prostate·M Y HeshmatS L Perry
Jul 16, 1983·Lancet·W C WillettC G Hames
Jan 1, 1984·Journal of Steroid Biochemistry·E HämäläinenP Pietinen
Dec 6, 1995·Journal of the National Cancer Institute·E GiovannucciW C Willett
Oct 4, 1995·Journal of the National Cancer Institute·Y WangW D Heston
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T FotsisL Schweigerer
Jan 21, 1995·Lancet·M Meydani
May 1, 1994·Epidemiology·L Le MarchandT Hirohata
Jan 1, 1994·Nutrition and Cancer·M J MessinaS Barnes
Oct 6, 1993·Journal of the National Cancer Institute·E GiovannucciW C Willett
Feb 16, 1994·Journal of the National Cancer Institute·P H GannM J Stampfer
Dec 1, 1996·The American Journal of Clinical Nutrition·J F DorganP R Taylor
Dec 11, 1996·International Journal of Cancer. Journal International Du Cancer·S O AnderssonH O Adami
Feb 5, 1997·Journal of the National Cancer Institute·M J Campbell, H P Koeffler
Jan 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H D VlajinacN I Kocev
May 16, 1997·International Journal of Cancer. Journal International Du Cancer·S HarveiL Vatten
Jan 1, 1997·British Journal of Cancer·T J KeyD T Bishop
Dec 16, 1997·International Journal of Cancer. Journal International Du Cancer·M B VeierødD S Thelle

❮ Previous
Next ❯

Citations

Sep 8, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Chih-Jen ChengShih-Hua Lin
Dec 4, 2003·Wiener klinische Wochenschrift·Edzard Ernst
Jul 2, 2014·The New Bioethics : a Multidisciplinary Journal of Biotechnology and the Body·Calum MacKellar
Mar 12, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Yi-Hsien LinJen-Hwey Chiu
Oct 29, 2014·HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues·Steven Weimer
Nov 20, 2010·Biochemical Pharmacology·Vaishali PannuRitu Aneja
Aug 25, 2005·Clinical Journal of Oncology Nursing·Annabelle M Smith
Dec 15, 2005·Nutrition and Cancer·Sanjeev Shukla, Sanjay Gupta
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alex SparreboomWilliam D Figg
Jun 19, 2004·Toxicologic Pathology·Duangrudee CherdwongcharoensukArtur P AGuas
Nov 11, 2011·The Cochrane Database of Systematic Reviews·Dragan IlicCraig Hassed
Jan 6, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Dong XueXiao-Zhou He
May 4, 2005·The Journal of Nutrition·Kirstie Canene-AdamsJohn W Erdman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.